LANZOLLA, Giulia
LANZOLLA, Giulia
DIPARTIMENTO DI SCIENZE MEDICHE E SANITA' PUBBLICA
Graves disease: latest understanding of pathogenesis and treatment options
2024-01-01 Lanzolla, G.; Marino, M.; Menconi, F.
HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation
2024-01-01 Khan, M. P.; Sabini, E.; Beigel, K.; Lanzolla, G.; Laslow, B.; Wang, D.; Merceron, C.; Giaccia, A.; Long, F.; Taylor, D.; Schipani, E.
IgG4 serum levels in Graves’ orbitopathy
2024-01-01 Comi, S.; Lanzolla, G.; Cosentino, G.; Maglionico, M. N.; Posarelli, C.; Menconi, F.; Santini, F.; Elisei, R.; Marino, M.
Long-term outcome of Graves’ orbitopathy following treatment with sirolimus
2024-01-01 Comi, S.; Cosentino, G.; Lanzolla, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Latrofa, F.; Rocchi, R.; Figus, M.; Santini, F.; Marino, M.
Osteoblastic erythropoietin is not required for bone mass accrual
2024-01-01 Lanzolla, G.; Merceron, C.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E.
Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency
2024-01-01 Lanzolla, Giulia; Sabini, Elena; Beigel, Katherine; Khan, Mohd Parvez; Sherry Liu, Xiaowei; Wang, Dian; Laslow, Brittany; Taylor, Deanne; Bellido, Teresita; Giaccia, Amato; Schipani, Ernestina
Editorial: News in Graves’ orbitopathy: patients management and treatments
2023-01-01 Lanzolla, G.; Sabini, E.
Oxidative phosphorylation in bone cells
2023-01-01 Sabini, E.; Arboit, L.; Khan, M. P.; Lanzolla, G.; Schipani, E.
Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)
2023-01-01 Schuh, A.; Ayvaz, G.; Baldeschi, L.; Baretic, M.; Bechtold, D.; Boschi, A.; Brix, T. H.; Burlacu, M. -C.; Ciric, J.; Covelli, D.; Curro, N.; Donati, S.; Eckstein, A. K.; Fichter, N.; Fuhrer, D.; Horn, M.; Jablonska-Pawlak, A.; Mandic, J. J.; Kahaly, G. J.; Konuk, O.; Langbein, A.; Lanzolla, G.; Marcocci, C.; Marino, M.; Miskiewicz, P.; Beleslin, B. N.; Perez-Lazaro, A.; Perez-Lopez, M.; Ponto, K. A.; Quinn, A.; Rudofsky, G.; Salvi, M.; Schittkowski, M. P.; Tanda, M. L.; Toruner, F.; Vaidya, B.; Hintschich, C. R.
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| Graves disease: latest understanding of pathogenesis and treatment options | 1-gen-2024 | Lanzolla, G.; Marino, M.; Menconi, F. | NATURE REVIEWS. ENDOCRINOLOGY | - |
| HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation | 1-gen-2024 | Khan, M. P.; Sabini, E.; Beigel, K.; Lanzolla, G.; Laslow, B.; Wang, D.; Merceron, C.; Giaccia, A.; Long, F.; Taylor, D.; Schipani, E. | JCI INSIGHT | - |
| IgG4 serum levels in Graves’ orbitopathy | 1-gen-2024 | Comi, S.; Lanzolla, G.; Cosentino, G.; Maglionico, M. N.; Posarelli, C.; Menconi, F.; Santini, F.; Elisei, R.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Long-term outcome of Graves’ orbitopathy following treatment with sirolimus | 1-gen-2024 | Comi, S.; Cosentino, G.; Lanzolla, G.; Menconi, F.; Maglionico, M. N.; Posarelli, C.; Latrofa, F.; Rocchi, R.; Figus, M.; Santini, F.; Marino, M. | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | - |
| Osteoblastic erythropoietin is not required for bone mass accrual | 1-gen-2024 | Lanzolla, G.; Merceron, C.; Khan, M. P.; Sabini, E.; Giaccia, A.; Schipani, E. | JBMR PLUS | - |
| Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency | 1-gen-2024 | Lanzolla, Giulia; Sabini, Elena; Beigel, Katherine; Khan, Mohd Parvez; Sherry Liu, Xiaowei; Wang, Dian; Laslow, Brittany; Taylor, Deanne; Bellido, Teresita; Giaccia, Amato; Schipani, Ernestina | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - |
| Editorial: News in Graves’ orbitopathy: patients management and treatments | 1-gen-2023 | Lanzolla, G.; Sabini, E. | FRONTIERS IN ENDOCRINOLOGY | - |
| Oxidative phosphorylation in bone cells | 1-gen-2023 | Sabini, E.; Arboit, L.; Khan, M. P.; Lanzolla, G.; Schipani, E. | BONE REPORTS | - |
| Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) | 1-gen-2023 | Schuh, A.; Ayvaz, G.; Baldeschi, L.; Baretic, M.; Bechtold, D.; Boschi, A.; Brix, T. H.; Burlacu, M. -C.; Ciric, J.; Covelli, D.; Curro, N.; Donati, S.; Eckstein, A. K.; Fichter, N.; Fuhrer, D.; Horn, M.; Jablonska-Pawlak, A.; Mandic, J. J.; Kahaly, G. J.; Konuk, O.; Langbein, A.; Lanzolla, G.; Marcocci, C.; Marino, M.; Miskiewicz, P.; Beleslin, B. N.; Perez-Lazaro, A.; Perez-Lopez, M.; Ponto, K. A.; Quinn, A.; Rudofsky, G.; Salvi, M.; Schittkowski, M. P.; Tanda, M. L.; Toruner, F.; Vaidya, B.; Hintschich, C. R. | BRITISH JOURNAL OF OPHTHALMOLOGY | - |